Wednesday, 1 February 2017

Microfluidics Market: Reduced Costs to Ensure Swift Uptake of Microfluidics Technology

Global Microfluidics Market: Snapshot
Microfluidics technology refers to of operating and controlling liquids with flow channels. The technique has picked up pace due to its growing applications in areas such as point of care devices and invitro diagnostic techniques for pregnancy kits and glucometer kits. The report states that the technology will show tremendous progress in the coming years due to its emerging applications in the fields of pharmaceutical, in-vitro diagnostics, and drug delivery industries. Owing to these reasons, the global microfluidics market is estimated to be worth US$12.45 bn by the end of 2025 as compared to US$4.76 bn in 2016. The market is expected to show a steady CAGR of 11.4% between 2016 and 2025.
The range of advantages offered by the global microfluidics products and devices such as accuracy, reduction in volume, liability, reduced costs, fast return on investments, and greater profit margins have proven to the key growth drivers. Furthermore, growing interest of market players in discovering various types of polymers in order to improve the compatibility of microfluidic products to cut down their manufacturing costs is also expected to work in favor of the overall market in the near future.
Acceptance of Cartridges and Reagents in Industries and Laboratories Drives Segment
On the basis of product, the global microfluidics market is fragmented into instruments, microfluidic chip, cartridges and reagents, and others. Of these, the cartridges and reagents held a leading share in the global market and the segment is expected to continue its dominance in the coming years. In terms of revenue, the total global microfluidics market held a share of 45.2% in the global market in 2016. The considerable acceptance of microfluidic products in laboratories and industries have provided cartridges and reagents this wide scope for growth. The report projects that the instruments and the microfluidic chip segments will closely follow the lead during the forecast period.
North America to Dominate Global Market with Well-established Healthcare Sector
On the basis of geography, the global microfluidics market is segmented into Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. As of 2016, North America held a major share in the overall market. The region is anticipated to show a persistent progress throughout the forecast period due to high adoption of innovative products. The regional market will also benefit from the well-established healthcare sector.
Asia Pacific is also expected to offer lucrative opportunities to the microfluidics market in the coming years. This regional market will be fueled by the growing pool of geriatrics who are prone to medical conditions and thus require diagnosis and care. The increasing technological advancements across Asia Pacific is also projected to propel the growth of the overall market. For instance, improvements in point of care diagnostic devices and invitro diagnostics technology have allowed vendors to products some of the superior microfluidics products in recent times. The growing awareness about new technologies in Asia Pacific, rising medical tourism, and growing healthcare infrastructure will prove to be pivotal to the positive trajectory of this regional market.
The important players operating in the global microfluidics market are Danaher Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc, RainDance Technologies, Inc., and F. Hoffmann La-Roche Ltd. The market is witnessing a high degree of competition due to the presence of several players.
Posted by at No comments:
Labels:

Aptamers Market grows with Rising support and participation of private organizations aiming to increase advancements in aptamer field

The growing use of aptamers in drug discovery, pharmaceutical studies, as well as disease treatment will help drive the global aptamers market through the current decade, says Transparency Market Research in a recent study. The report is titled ‘Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.’ According to the report, the global aptamers market was valued at US$93.0 million in 2012, and it is expected that the market will reach a valuation of US$4,333.0 million by 2019. This translates to a remarkable CAGR of 73.1% between 2013 and 2019.
However, the report also warns that the growth in the global aptamers market will be restrained to some extent ethical issues associated with aptamers derived from animals. This drawback will be further compounded by strict regulatory mandates designed around aptamers. However, these drawbacks can be overcome by companies in the global aptamers market by modifying aptamers chemistry. For instance, animal-derived aptamers can be replaced by aptamers obtained via the in-vitro process.
For the purpose of this study, the global aptamers market is segmented on the basis of types, applications, and geography. The types of aptamers studied in the report include peptide and nucleic acid aptamers. The segment of nucleic acid aptamers was not only the largest as of 2012, but is also expected to be the fastest growing over the report’s forecast period. This is chiefly owing to the widespread use of nucleic acid aptamers in the R&D sector.
Likewise, the applications analyzed in the report are: Diagnostics, therapeutics development, research and development, and others. Of these, the diagnostics segment will report consistent growth over the next four years as the demand for aptamers for biomedical diagnostics, biomarker development, and molecular imaging remains steady. However, in terms of pace of growth, therapeutics development applications will outpace all other application segments over the report’s forecast period.
From the geographical standpoint, the aptamers market for the following regions is studied: North America, Asia Pacific, Europe, and Rest of the World. Thanks to several key players in the aptamers market being based in the United States, the North America region was identified as the largest market for aptamers in 2012. This factor also creates an environment that fosters R&D related to aptamers.
The Europe aptamers market was the second largest from the global standpoint. According to the findings of the report, Europe constituted about 35% of the global aptamers market in 2012. Small scale industries play a key role in keeping the Europe aptamers market firmly on the growth track. The Asia Pacific market is currently brimming with opportunities in diagnostics and pharmaceuticals, enabling the region to post the highest CAGR between 2013 and 2019.
TMR’s report also conducts a detailed analysis of the competitive scenario in the global aptamers market, which is characterized by intense competition. A high degree of competition has stimulated higher investments the development of novel aptamers. Leading market participants include: Somalogic, Inc., Aptamer Science, Inc. NOXXAN Pharma AG, and Aptagen, Inc.
Posted by at No comments:
Labels:

Growing Trends in Regenerative Medicine Market

Regenerative medicines are an emerging field of medical science aimed at regeneration, repair, or replacement of damaged tissue and organs. As per the U.S. National Institute of Health, regenerative medicine is the procedure of creating functional tissues to repair and/or replace nonfunctional organs or tissues. With regenerative medicines, tissues or organs that have lost their functioning power due to congenital defects, age, and external or internal damage are repaired or replaced. Some of the application areas of regenerative medicines are neurology, cardiovascular, orthopedic, and musculoskeletal disorders.
Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.
The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.
Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.
By technology, the global regenerative medicine market is classified into stem cell therapy, tissue engineering, and biomaterials. In 2012, the biomaterials segment dominated the global regenerative medicine market due to factors such as favorable reimbursement policies. Moreover, strong demand for biomaterials is predicted to propel the segment in the coming few years.
Posted by at No comments:
Labels:

North America Wheelchair Accessible Vehicle Converters Market Outlook to 2024 Latest Industry Forecast Report

The North America wheelchair accessible vehicle (WAV) converters market is consolidated, with the top three players – BraunAbility, Vantage Mobility International, and Mobility Ventures LLC – accounting for over 65% in 2015. Transparency Market Research has observed that WAV manufacturers and vehicle converters are increasingly focusing on strengthening their distribution networks, developing a steady sales force, and conducting awareness programs in order to increase the adoption of WAVs over the forecast period.
Transportation companies are also looking to capitalize on the opportunities presented by this market through WAV taxi services. For instance, in July 2015, Uber Technologies, Inc. announced the launch of UberACCESS, which provides mobility vehicles for disabled customers. Wheelchair accessible vehicle taxi services are gaining traction in the U.S. and this is expected to give the WAV converters market a considerable boost in the coming years.
The value of the North America wheelchair accessible vehicle converters market was pegged at US$781.8 mn in 2015 and is expected to reach US$1.9 bn by 2024, registering a CAGR of 11.1% therein.
By Entry Modality, Ramps Present Most Lucrative Opportunities for Players
On the basis of size of vehicle, full-sized vehicles are expected to account for a 73.1% share in the wheelchair accessible vehicle converters market by 2024. Small-sized vehicles, on the other hand, form the most attractive segment. This segment is projected to expand at a strong CAGR of 11.4% from 2016 to 2024.
By entry modality, ramps form the leading segment of the wheelchair accessible vehicle converters market in North America and this segment is anticipated to exhibit high growth through the forecast period.
From a geographical standpoint, the U.S. market is estimated to account for an 88.3% revenue share by 2024, emerging as the clear leader in the North America wheelchair accessible vehicle converters market. The U.S. is also projected to be the most lucrative segment by 2024.
Introduction of Preemptive Accommodations by WAV Manufacturers a Key Marketing Strategy
One of the key factors driving the North America market for wheelchair accessible vehicle converters is the significant prevalence of people with disabilities. A recent study published by the Centers for Disease Control and Prevention (CDC) states that one out of every five adults in the U.S. has a disability. This translates to roughly 53 million adults currently living with some form of disability. Disabled World, an independent news portal, reveals that an estimated 6.8 million community-resident Americans use mobility assistive devices, of which, at least 1.7 million individuals are wheelchair or scooter riders. “With the number of people living from disabilities on the rise, the demand for wheelchair accessible vehicle converters is bound to grow,” the TMR analyst states.
Looking to increase the adoption rate of wheelchair accessible vehicles and offer more benefits to customers, WAV manufacturers are focusing on integrating advanced technologies with their products. The introduction of preemptive accommodations is one such example, wherein WAV manufacturing companies are partnering with parking authorities in major cities to notify WAV users regarding the availability of parking spaces. Developments such as these are sure to boost the wheelchair accessible vehicle converters market in North America.
On the flip side, the high cost of wheelchair accessible vehicles and low awareness among potential customers are expected to significantly hamper the adoption rate of mobility vehicles, thereby hurting the wheelchair accessible vehicle converters market in North America.
This review is based on the findings of a TMR report titled “Wheelchair Accessible Vehicle Converters Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
Posted by at No comments:
Labels:

PACS and RIS Market in Asia Pacific to Witness Considerable Growth by 2024

Global PACS and RIS Market: Snapshot
The global market for Picture archiving and communication systems (PACS) and radiology information systems (RIS) have witnessed rise at a significant pace in the past few years owing to the efficiency they enable in the proper management of data in healthcare facilities. The mounting rise in demand for digitization in the healthcare industry will continue to drive the market in the next few years as well.
Transparency Market Research estimates that the global PACS and RIS will exhibit a promising 7.0% CAGR over the period between 2016 and 2024, rising from US$2.2 bn in 2015 to US$3.9 bn in 2024.
Cloud-based PACS and RIS to Witness Most Promising Growth
On the basis of product type, the global PACS and RIS market witnessed the emergence of PACS as the leading segment in terms of revenue in 2015. The widespread use of PACS and the continuously rising demand across the cardiology and orthopedics sectors are expected to help PACS retain its dominance over the forecast period as well. Of the variety of types of PACS products available in the global market, the segment of oncology PACS is expected to be the segment with the most significant growth over the report’s forecast period. The rising prevalence of a variety of cancers is expected to be the leading factor to drive the increased demand for oncology PACS.
From the components perspective, the services segment accounts for the dominant share in the global PACS and RIS market. The demand for PACS and RIS services has significantly increased in the past few years owing to the increased need for the regular maintenance and servicing of software and hardware. In terms of deployment, the market is presently dominated by the web-based segment, owing to the high demand for multi-modality support for the effective management of medical image practice workflow. However, the cloud-based segment is expected to witness the most promising growth over the forecast period owing to cost effectiveness and flexibility provided by the cloud model.
Asia Pacific PACS and RIS Market to Lead to Most Promising Growth Opportunities
From a geographical perspective, the global PACS and RIS market is dominated by North America, which held a share of nearly 45% in 2015. The vast rise in effective healthcare services to tackle the mounting cases of a number of chronic diseases and the substantial rise in government funding to enable this are the key factors to have helped the North America market gain the leading share in the market in the recent years. The PACS segment held the dominant share in the North America market in the same year, chiefly owing to the vast range of applications in the fields of oncology and cardiology.
Nevertheless, the PACS and RIS market is expected to witness the most promising growth opportunities in Asia Pacific over the report’s forecast period, chiefly owing to the vast rise in the numbers of medical images and the need to move to a technologically advanced and digitized medical data management systems in the burgeoning healthcare sector in the region.
Some of the key companies operating in the global PACS and RIS market profiled in the report are Fujifilm Holdings Corporation, GE Healthcare, Agfa Healthcare, Philips Healthcare, Allscripts Healthcare Solutions, Inc., McKesson Corporation, and Siemens Healthineers.
Posted by at No comments:
Labels:

Urinalysis Market: Aggressive Research Activities Stimulating Market Growth

Global Urinalysis Market: Snapshot
The global market for urinalysis has been growing at a fast rate due to increased incidence of diabetes among people across the globe. On a global scale, the major cause of end-stage renal disease and kidney failure is diabetes. The International Diabetes Federation (IDF) found that approximately 338 million new cases of diabetes were recorded in 2014, while as many as 3.2 million suffered from end-stage renal disease (ESRD) in 2015.
Urinalysis is a set of tests for detecting some common diseases such as kidney disorders, diabetes, liver problems, and urinary tract infections. The test consists of several microscopic, visual, and chemical examinations that identify cells, levels of creatinine, epithelial cells, and substances such as casts or crystals in the urine. These detections are crucial in the process of disease diagnosis. These tests are also conducted during routine pregnancy check-ups, when one is admitted to the hospital, and even before a surgery.
The global market for urinalysis is expected to grow steadily with a CAGR of 5.4%. In 2015, the market was valued at US$929.9 mn, which will rise to US$1.5 bn by the end of 2024.
By Test Setting, Laboratory-based Segment to Continue to Grow
In terms of test setting, the urinalysis market was dominated by the laboratory-based segment in 2015 and is expected to continue to hold its dominant position over the coming years. This development is due to the increasing geriatric population, increased frequency of unhealthy lifestyles, and growing incidence of infectious diseases worldwide.
On the basis of type of test, the biochemical segment lead the urinalysis market in 2015, on account of the widely accepted usage of dipsticks (reagent strips) that detect the presence of constituents in urine. Also, it is convenient to operate this technique as it is readily available. The hospital segment leads the market in terms of end users in the global market for urinalysis.
Among the key products in the urinalysis market, consumables occupy the foremost position. High rate of acceptance of single-use, rigid, and sterile disposable products is boosting the growth of this segment. Under the consumables segment, plastic consumables will emerge as a terrain for immense opportunities.
Japan at Headmost Position in Asia Pacific Segment
Among the key geographical segments, it was North America that led the global market in 2015, accounting for a nearly 30.0% share. The U.S. is home to around 26 million kidney patients, according to the findings of National Kidney Foundation. Increasing incidence of urinary tract infections in the U.S. is also responsible for the expansion of the urinalysis market in North America. Latin America, too, will grow at an impressive CAGR between 2016 and 2024. The key reasons for growth are favorable government policies, massive population base, and a large patient pool.
Asia Pacific is projected to be a major market furnishing lucrative opportunities, with Japan at the foremost place. An increase in aging population, rapid industrialization, growing number of laboratory diagnosis tests, and high adoption of point-of-care testing have been the major reasons for Japan’s rise as a key regional market. Apart from Japan, India and China are also expected to expand their urinalysis market on account of numerous infrastructural development projects.
The major companies in the global urinalysis market include Danaher Corporation (Beckman Coulter, Inc.), ARKRAY, Inc., Sysmex Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Siemens Healthineers, 77 Elektronika Kft, and Mindray Medical International Limited.
Posted by at No comments:
Labels:

Global Personal Mobility Devices Market Gets a Boost with Health Insurance Coverage Schemes

Global Personal Mobility Devices Market: Overview
An increase in the number of disabled population, either with permanent or temporary disability, is expected to boost demand for personal mobility devices, finds Transparency Market Research (TMR). Any device that assists in the transportation of human beings is a personal mobility device. It runs either manually or on a battery, and is usually designed for a single person.
The report provides an in-depth analysis of key factors in the market for personal mobility devices, some of which include market size, market drivers and restraints, growth opportunities, forecasts, detailed overview, and key market trends. The value chain analysis, market attractiveness analysis, competitive landscape, and key market segments are also covered. Porter’s Five Forces analysis has been given along with a description of assumptions and research methodology. Each company has been studied in terms of financial overview, product portfolio, recent developments, and business strategies.
According to the findings of TMR, in 2014, the global personal mobility market was estimated at US$ 6.65 bn. It is projected to exhibit a promising CAGR of 7.30% during the forecast period, attaining a revenue worth US$ 12.7 bn in 2023.
Global Personal Mobility Devices Market: Drivers and Restraints
The steady increase in the aging population across the globe has been fuelling the demand for personal mobility market worldwide. Besides this factor, the rising number of care-giving services necessary for people with disability is also giving impetus to the market. The growing number of patients suffering from rheumatoid arthritis and osteoporosis, considerable increase in disposable incomes of people, and beneficial government policies, along with technological progress in the domain of personal mobility devices are factors contributing towards market growth.
On the other hand, the market for personal mobility devices will face restraints on account of the high costs of these devices, coupled with low rate of adoption of digitized devices. However, conducive policies of governments and large scale grants from international organizations will aid in the expansion of personal mobility devices market over the coming years.
On the basis of device type, the key segments of the personal mobility devices market include medical mobility aids and ambulatory devices and medical furniture and bathroom safety products. The medical mobility and ambulatory devices segment has been further segmented into mobility scooters, crutches, canes, walkers, and wheelchairs. The medical furniture and bathroom safety products segment has been further categorized into medical beds, showers and commodes, bars and railings, stair lifts, and patient lifts.
Global Personal Mobility Devices Market: Regional Outlook
Based on geography, the global market for personal mobility devices has been categorized into five regions: Asia Pacific, Latin America, Middle East and Africa, North America, and Europe. These regions have been further segmented into chief countries responsible for market growth. These include Brazil, the U.K., China, Italy, Mexico, the U.S., China, France, Saudi Arabia, Germany, Canada, Spain, India, and South Africa. Each geographical segment has been studied in terms of volume, market size, product segments and forecast. The personal mobility devices will witness a surge in demand as the geriatric population in Asia Pacific (in countries such as India and China in particular) increases.
Companies Mentioned in the Report
The key vendors operating in the global market for personal mobility devices discussed in the report include Permobil AB, Argo Medical, Ottobock Healthcare, GF Health Products, Inc., Invacare Corporation, Sunrise Medical LLC, Stryker Corporation, Hill-Rom Holdings, Inc., Amigo Mobility International, Inc., ArjoHuntleigh, Patterson Companies, Inc., and Pride Mobility Products Corporation.
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)